If you have any questions, suggestions or complaints, please submit them below
Currently, we sell our products in 11 CIS countries and aim to be competitive with the timing of the launches for our pipeline products. Our goal is to increase Arterium’s presence throughout the globe by licensing to strategic partners and supplying high quality products.
We are seeking to out-license or partner on a number of our original products in cardiology, urology, and neurology.
An angio-protector (capillary stabilizing drug), L-LYSINE AESCINATE®, is a unique product with triple mechanism of action: it decreases the vascular permeability, improves rheological properties of blood, has anti-inflammatory effect. In 2010, It was the leading angio-protector on Ukrainian pharmaceutical market. (С05СХ 03**| 1mg/ml solution for intravenous injection only in 5 ml vials №10 | Post-traumatic, intra- and postoperative edemas of any localization).
THIOTRIAZOLIN® is a metabolic medication for treatment of hepatobiliary system malfunctions. In 2010, the product was third in cardiology segment on the Ukrainian pharmaceutical market in terms of revenue. (С01ЕВ | Tablets №30 and Tablets №90 | Solution for injection 2 ml or 4 ml №10 | In combined therapy of ischemic heart disease: angina, myocardial infarction, post-infarction cardiosclerosis, adjunctive treatment for heart rhythm disorders. Used in combined therapy of chronic hepatitis, alcoholic hepatitis, fibrosis, and cirrhosis of liver).
UROLESAN® is a herbal medication with diuretic, spasmolytic, litholytic, antibacterial, and anti-inflammatory effect. In 2010, the product was second in terms of units sold in the urology sector on the Ukrainian market. (G04B X | Capsules №40, Capsules №10; G04B D10** | Drops 25 ml №1; G04B D10** | Syrup 180 ml №1 | Acute and chronic infections of the urinary tract and kidneys (cystitis and pyelonephritis), urolithiasis and uratic diathesis (prevention of calculi formation after their removal), chronic cholecystitis (including calculous), biliary dyskinesia, cholelithiasis).
THIOCETAM® is a combination drug (including thiotriazolin and piracetam) indicated for treatment of cognitive disorders of vascular and destructive genesis. The product also improves short-time and long-time memory and patients’ neurological condition. (N06BX** | Solution for injection 5 ml №10 or 10 ml №10; N06BX | Tablets №60).
Contact us: email@example.com